We innovate crops to provide high-value, healthy food ingredients to help meet consumer demand for a healthier diet. We’ve also developed a portfolio of agronomic traits that enable farmers around the world to be more productive amidst challenging economic and environmental conditions.
Making wheat cool again.
Americans get an average of one-quarter or 500 calories per day from wheat, and according to the United Nations, bread wheat accounts for 20 percent of the human diet globally. Yes, we love wheat.
That’s why we developed our GoodWheat portfolio of branded wheat flour ingredients – ingredients that offer healthier enriched and whole grain wheat options while providing the same baking quality, taste, and texture as traditional wheat.
Naturally produced, GoodWheat ingredients can simplify ingredient formulations and ultimately, satisfy the increasing consumer demand for clean labeling. We are advancing exciting near-term opportunities with partners who share our passion for helping to lead the future of healthy foods.
Arcadia’s high-fiber Resistant Starch GoodWheat is available now at formulation scale, and our Reduced Gluten GoodWheat is on track for an upcoming commercial launch. We’re also working on other naturally-produced, proprietary wheat varieties that deliver health benefits for consumers and brand-differentiating attributes for consumer packaged goods companies.
Arcadia Specialty Genomics™
Getting to the genetic roots of cannabis.
With a dedicated business unit focused on the optimization and standardization of cannabis, Arcadia Specialty Genomics brings proven ability to bring innovative traits to the market through advanced breeding and gene editing in wheat, soybeans and other complex plant genomes.
The historically clandestine nature of the breeding and production of cannabis has produced suboptimal genetics, a lack of Information regarding the origin of the plant genetics, and a lack of quality agricultural standards.
The result? Inconsistent quality and significant waste, and a burning demand for quality genomics and agronomic excellence. That’s why we created Arcadia Specialty Genomics™, a new unit at Arcadia focused on genetic improvement of cannabis and other crops. We are creating value by developing a proprietary germplasm estate and traits improving plant quality and productivity in cannabis—working within federal legal guidelines.
At Arcadia, we’ve long proven our ability to optimize plants for their value to growers and consumers and to transform commodity crops for improved functional nutrition. Now, through Arcadia Specialty Genomics, we will create hemp-based innovations that allow farmers to be more productive and enable consumer packaged good companies to differentiate their brands in the marketplace.
Delivering a Healthy Lifestyle.
Plant-based oils can be a good source of important nutrients. Many oils, however, are not rich enough in key nutrients to deliver health benefits.
To help solve this challenge, we’ve worked with safflower plants – a robust, oil-rich plant – to produce high levels of nutrients that are not prevalent in our diets.
We launched our first product, SONOVA® GLA Safflower Oil in 2012 and maintain an active nutritional oils development program.
Improving Animal Nutrition.
The same products that contribute to healthy people can have a positive impact on animals.
That’s why we’ve created a line of nutritional ingredients for animal food manufacturers designed especially for farm and companion animals based on the same technologies we’ve developed for people.
Helping Farmers Meet Economic And Environmental Challenges.
Today’s farmers face a multitude of challenges, both environmental and economic. From a growing global population and changing planet to ever-fluctuating commodity crop prices, farmers need tools to help maximize farm productivity and minimize environmental impact.
For more than a decade we’ve been working with growers to develop new plant varieties to help address some of their greatest unmet needs – crops resistant to abiotic stresses. Abiotic stresses are caused by non-living environmental factors such as heat, drought, nutrient availability and salinity. These stresses can have an even greater impact on yield than biotic stresses such as insects, weeds and disease, yet most commercial technologies focus on biotic stresses.
Solving abiotic stress impact on plants is a significant plant biology challenge. Our team of researchers and our partners around the world have achieved exciting milestones as our product pipeline moves closer to commercialization.
Raj Ketkar President and Chief Executive Officer
Raj Ketkar joined Arcadia as president and chief executive officer in May 2016. He brings nearly 35 years of agriculture and agricultural biotechnology business experience in the U.S. and internationally, including more than 30 years in a variety of business, operations, and strategy roles for Monsanto Company. His positions included managing director of the Mahyco-Monsanto Biotech joint venture in India and director of biotechnology strategy. Mr. Ketkar holds a master’s degree in chemical engineering from Oklahoma State University and a master’s of business administration from the University of New Orleans.
Matthew Plavan Chief Financial Officer
Matthew Plavan joined Arcadia as chief financial officer in September 2016. He brings nearly 30 years of financial and executive leadership experience in biotech, healthcare and high technology sectors. Prior to joining Arcadia, Mr. Plavan served as CFO, COO and CEO of Cesca Therapeutics, Inc., and CFO of Strion Air, Inc. and Reason, Inc. He also held executive finance positions with McKesson Corporation and audit and advisory management positions with Ernst & Young. Plavan is a certified public accountant and earned a bachelor’s degree in business economics from the University of California, Santa Barbara.
Sarah Reiter Chief Commercial Officer
Sarah Reiter joined Arcadia as chief commercial officer in March 2018. She has over 20 years of experience in agriculture with a strong focus on crop protection and sustainability. Prior to joining Arcadia, Ms. Reiter was the USA country head for STK Bio-ag Technologies and global product manager for biologics for Bayer CropScience. She previously served as vice president of marketing and communications for AgraQuest and served in several positions with Syngenta USA. Ms. Reiter holds a bachelor’s degree in English from the University of California, Davis and a master’s certificate in business administration from the Villanova School of Business.
BOARD OF DIRECTORS
Kevin Comcowich is chair of Arcadia’s board of directors and has served as a director since October 2016. Mr. Comcowich brings extensive business and financial leadership experience and a proven track record of success in investment management and global capital market strategies. He most recently served as the chief executive officer and portfolio manager of HTX Energy Fund in Houston, Texas. He was previously the president and chief investment officer (CIO) of Sound Energy Partners and served as CIO and research analyst for Southport Energy Plus Partners fund. Mr. Comcowich received his MBA from the University of Indiana and earned his bachelor’s degree from the College of the Holy Cross.
Albert D. Bolles, Ph.D. joined the board of directors in May 2018. He most recently served as the executive vice president, chief technology and operations officer of ConAgra Foods, a leading consumer products food company, where he directed the development and execution of multiple product innovations. Prior to ConAgra, Dr. Bolles was the vice president of worldwide research and development for PepsiCo Beverages and Foods and the research and development director for Gerber Foods. He is a graduate of Michigan State University, where he earned Ph.D. and M.S. degrees in food science and a bachelors’ degree in microbiology. Dr. Bolles holds several patents and has won numerous awards for his contributions to food science, the industry and academics. He currently serves as a director for Landec Corporation.
Raj Ketkar became a member of the board of directors in June 2016, after joining the company as president and chief executive officer in May 2016. He brings nearly 35 years of agriculture and agricultural biotechnology business experience in the U.S. and internationally, including more than 30 years in a variety of business, operations, and strategy roles for Monsanto Company. His positions included managing director of the Mahyco-Monsanto Biotech joint venture in India and director of biotechnology strategy. Mr. Ketkar holds a master’s degree in chemical engineering from Oklahoma State University and a master’s of business administration from the University of New Orleans.
Eric J. Rey joined the board of directors in June 2017. He is one of the founders of Arcadia Biosciences and served as president and CEO, as well as a director, until 2016. Prior to founding Arcadia, Mr. Rey was a partner with Rockridge Group, a management consulting firm for early-stage companies developing genomic, biopharmaceutical, nutraceutical, crop protection, animal nutrition and health, alternative crop and industrial products. He previously served as vice president of operations with Calgene, Inc., including two years with Monsanto Company following its acquisition of Calgene. Mr. Rey has a bachelor’s degree in plant science from the University of California, Davis. He currently serves as a director for Phytelligence, Inc. and Texas Crop Science, LLC.
Lilian Shackelford Murray joined the board of directors in June 2018 and previously served as an observer to the Arcadia board from March 2007 until May 2015. Ms. Murray is the founder and manager of Dovedale Investments and managing member of Saints Capital V. She is a former managing director and senior healthcare banker at Prudential Volpe Technology Group and its predecessor, Volpe, Brown Whelan, and held senior positions with Wheat First Securities and Dean Witter Reynolds. Ms. Murray received an MBA from Harvard Business School and a bachelor’s degree from the University of Virginia. Her prior board experience includes service as a director of eMedicine.com, Inc., Extended Care Information Network, Inc. and LifeMasters Supported SelfCare, Inc.
Gregory D. Waller joined Arcadia’s board of directors in June 2017. He is the former chief financial officer (CFO) of Ulthera Corporation, a privately-held company providing ultrasound technology for aesthetic and medical applications, which was acquired by Merz North America in 2014. Previously, Mr. Waller was CFO of Universal Building Products and Sybron Dental Specialties, Inc., and vice president and treasurer of Kerr, Ormco Corporation, and Metrex. Mr. Waller has an MBA with a concentration in accounting from California State University, Fullerton. He has extensive experience serving on the boards of public companies and currently serves as a director for CHF Solutions and Endologix Corporation.
Amy Yoder joined the Arcadia board in August 2017. She is president and CEO of Anuvia Plant Nutrients, a company that creates enhanced plant nutrition products from recycled organic waste sources. Ms. Yoder is the former president of Arysta LifeScience and has held a variety of sales, marketing and executive positions with companies throughout the agricultural and related industries, including Spectrum Brands, BioLab and United Agri Products. Ms. Yoder received a bachelor’s degree in agricultural technology and systems management from Michigan State University. She has served on boards of various agricultural associations and universities and currently serves as a director for Compass Minerals International.